C86.4 ICD-10-CM Code: Blastic NK-cell lymphoma
C86.4 isn’t billable on its own. Choose one of the 2 billable codes beneath it, the one the documentation supports.
Official description
C86.4Blastic NK-cell lymphoma
ICD-10-CM diagnosis code · United States clinical modification
Billable codes under C86.4
C86.4 can’t be reported on its own. Choose the code below that matches what the note documents.
Where C86.4 sits
- 1
Chapter 2
Neoplasms (C00-D49)
- 2
Section
Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
- 3
Category C86
Other specified types of T/NK-cell lymphoma
- 4
Code C86.4
Blastic NK-cell lymphoma
Notes for this code
Inclusion terms
- Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Code first
No “code first” instruction is listed for C86.4.
Use additional code
No “use additional code” instruction is listed for C86.4.
Excludes1
Conditions that should not be reported together with this code.
No Excludes1 note is listed for C86.4.
Excludes2
Conditions not included here that may be reported separately when present.
No Excludes2 note is listed for C86.4.
Source and release
- Data release
- U.S. ICD-10-CM · FY 2027
- Effective date
- Oct 1, 2026
- Publisher
- Vero Scribe Inc.
This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.
Frequently asked questions
What does ICD-10-CM code C86.4 mean?
C86.4 is the FY 2027 U.S. ICD-10-CM code for “Blastic NK-cell lymphoma.”
Is C86.4 a billable or specific ICD-10-CM code?
No. C86.4 has 2 billable codes beneath it in the FY 2027 reference data. Select the code that matches the documentation and confirm the active code set and payer requirements.
Where is C86.4 located in ICD-10-CM?
C86.4 is listed in Chapter 2, Neoplasms (C00-D49), within Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96) (C81–C96), under category C86, Other specified types of T/NK-cell lymphoma.
What coding notes are listed for C86.4?
Its listed inclusion terms are Blastic plasmacytoid dendritic cell neoplasm (BPDCN). No code-first instruction is listed. No Excludes1 note is listed. No Excludes2 note is listed.